Company Announcements

Beckley Psytech announces £14m raise to conduct clinical trials on psychedelic medicine pipeline

Press Release

Company Announcements

Meet our new scientific advisors

We are very excited to announce that Joanna Neill, Professor of Psychopharmacology at the University of Manchester, and Dr Mike Emanuel, former vice president of global clinical operations for EMEA at Johnson & Johnson, are joining our Scientific Ad... Read More

Company Announcements

Beckley Psytech appoints renowned psychedelic experts to Scientific Advisory Board

Beckley Psytech, the psychedelic medicine company, has appointed a series of respected figures from the psychiatric and psychedelic research fields to its Scientific Advisory Board, bringing decades of expertise to its research programme.

Company Announcements

Meet our new Scientific Advisory Board!

Renowned experts bring decades of experience to Beckley Psytech

Company Announcements

Beckley Psytech raises £3m to develop ground-breaking psychedelic medicines

Beckley Psytech, the psychedelic medicine company, has raised £3m of Series A funding to develop a pipeline of psychedelic drugs into licensed pharmaceutical medicines for treating psychiatric and neurological diseases. Investors in the round includ... Read More